Description
Axitinib is listed in the oncology-focused API portfolio. The page is a technical overview only; clinical, regulatory and commercial status must be established from approved product documentation.
← Back to all products
Oncology API / Pharmaceutical technical profile
Axitinib
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Category: Oncology APICAS No.: 319460-85-0Formula: C22H18N4OS
Swati Industries portfolio01 02 03
Chemical & technical profile
Product nameAxitinib
CategoryOncology API
CAS No.319460-85-0
Molecular formulaC22H18N4OS
Molecular weight386.5 g/mol
PubChem CID6450551
Research & Development
Impurity identification and fate mapping; genotoxic-impurity risk assessment where relevant; robust assay/related-substances methods; solid-state characterization; stability and packaging studies.
Analytical testing
Identity by IR/LC-MS/NMR; assay and related substances by HPLC/UPLC; residual solvents by GC; water content; XRPD/DSC and particle-size testing where specification-relevant.
Verified chemical reference
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Open PubChem reference ↗Technical overview only; not a validated manufacturing process or a claim of company capability. Confirm chemical form, CAS No., grade and specifications from the approved specification and batch COA.